NICM
ACLX

Neo Ivy Capital Management’s Arcellx ACLX Stock Holding History

Neo Ivy Capital Management’s Portfolio ACLX Stock Details ACLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,948
Closed -$259K – 347
2025
Q1 		$259K Buy
+3,948
New +$267K 0.08% 218

Other funds holding ACLX

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

Neo Ivy Capital Management's ACLX Position: Q2 2025 in Review

Neo Ivy Capital Management sold out of Arcellx (ACLX) in Q2 2025, closing a stake of 3,948 shares — an estimated $259K sold.

Neo Ivy Capital Management first reported a position in ACLX in Q1 2025 and held it in 1 quarter. The position peaked at $259K in Q1 2025. 202 funds tracked by Wall St. Rank hold ACLX as of Q2 2025.

  • Neo Ivy Capital Management reported no remaining Arcellx position as of Q2 2025 after selling out during the quarter.
  • Neo Ivy Capital Management sold 3,948 Arcellx shares in Q2 2025, an estimated $259K.
  • Neo Ivy Capital Management first reported a position in Arcellx in Q1 2025 and held it in 1 quarter.
  • Neo Ivy Capital Management's Arcellx position peaked at $259K in Q1 2025.
  • 202 funds tracked by Wall St. Rank held Arcellx as of Q2 2025.

Based on Neo Ivy Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.